Across TCGA pan-cancer cohorts, MIR593 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated MIR593 data layer.
The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MIR593 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR593 expression acts as an unfavorable survival marker, although some lineages such as UCS and HNSC show a favorable association.
DLBC, COAD, and THCA are the cancer types where MIR593 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.